K. Peter Hirth is listed as a director on 5 SEC Form D filings by 2 issuers between Aug 2013 and Feb 2025: Aligos Therapeutics, Inc. (South San Francisco, CA — biotechnology — 2025; $105M reported sold to 38 investors) and KINEMED INC (Emeryville, CA — biotechnology — 2013–2015; $8.4M reported sold to 131 investors).
What this means 2 separate companies raised money with this person listed as director, over about 12 years. Across those companies the filings report $113.4M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for K. Peter Hirth and found 6 differences, 2 worth asking the sponsor about: Paid seller listed without a CRD number: Jefferies LLC; Paid seller listed without a CRD number: Piper Sandler & Co; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.